Thyroid nodule laboratory findings

Thyroid nodule Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Thyroid nodule from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic study of choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Thyroid nodule laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Thyroid nodule laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Thyroid nodule laboratory findings
CDC on Thyroid nodule laboratory findings
Thyroid nodule laboratory findings in the news
Blogs on Thyroid nodule laboratory findings
Directions to Hospitals Treating Thyroid nodule
Risk calculators and risk factors for Thyroid nodule laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Laboratory findings in a patient with a thyroid nodule may reveal abnormalities in serum thyrotrophin, serum antithyroperoxidase, free T4, T3, serum thyroglobulin and plasma metanephrines. These findings may vary depending upon whether the nodule is hot or cold.

Laboratory Findings

Test	Indication	Finding
Serum thyrotropin	In all thyroid nodules	Increased in hot nodules that secrete TSH Normal/Decreased in most of the cold/malignant nodules
Serum antithyroperoxidase level	If suspected to Hashimoto's thyroiditis	Increased
Free T4	If suspected to hot, thyroid hormone producing nodule	Increased
T3	If suspected to thyrotoxicosis	Increased
Thyroglobulin	Routine measurement is not recommended by ATA	Increased May be elevated in most thyroid diseases and are an insensitive and nonspecific test for thyroid cancer
Basal serum calcitonin	In patients with positive family history of medullary thyroid carcinoma In any patients with family history of MEN In any patients with concomitant hormonal abnormalities	Increased Greater than 100 pg=mL, medullary cancer is likely present 39 Routine measurement: Not recommended due to unresolved issues of sensitivity, specificity, and costeffectiveness
Plasma metanephrine testing	In patients suspected to MEN to evaluate pheochromocytoma	Increased
24-hour urinary collection for catecholamines and metanephrines

Molecular markers

Thyroid specific molecular markers may be helpful in patients with intermediate cytology on FNA to decide on disease management:

• BRAF
• RAS
• RET
  • Mostly seen in papillary thyroid cancer (PTC)
• Pax8-PPARg
• Galectin-3